The Diabetes Control and Complication Trial (DCCT) was a clinical trial aimed at comparing intensive treatment, i.e., at least 3 insulin injections a day, to the traditional treatment, once or twice a day for Type 1 diabetes mellitus (T1DM) patients. This evidence concerns the gene INS and type 1 diabetes mellitus.